Company Number: 12840501

Analysis Date: 2025-07-20 14:50 UTC

1. Executive Summary
   CLARKE & CARRIE LTD operates within the "Other human health activities" sector as a micro-sized private limited company. Despite its active status and operational presence since 2020, the company is currently experiencing financial distress, reflected in consecutive years of negative net assets and a loss in the latest financial year. This positions the firm as a small player with limited market footprint and pressing financial challenges that must be addressed strategically to ensure survival and future growth.

2. Strategic Assets

• Niche Industry Focus: Operating under SIC code 86900, the company is engaged in specialized human health activities which likely require specific expertise and regulatory compliance, providing some entry barriers to competitors.
• Low Overhead Structure: With no fixed assets and minimal staff (average 1 employee), the company maintains a lean operational model, which could offer flexibility and lower fixed costs relative to competitors.
• Experienced Leadership: Directors have been in place since inception and 2022, suggesting some continuity in management, which is critical in navigating early-stage challenges.

3. Growth Opportunities

• Revenue Diversification: The company’s turnover of approximately £48.5k with no staff costs or material expenses indicates an opportunity to expand service offerings or increase sales channels to stabilize and grow revenue streams.
• Capital Injection and Restructuring: The current negative net assets (£-16,171) and negative working capital highlight an urgent need for financial restructuring or external funding to restore solvency and enable investment in growth initiatives.
• Market Expansion: Given the human health niche, there is potential to leverage partnerships with healthcare providers or to innovate service delivery models, particularly in emerging health tech or community health services.
• Digital Transformation: Adoption of technology solutions to improve efficiency, client reach, or service differentiation could unlock market opportunities and competitive differentiation.

4. Strategic Risks

• Financial Instability: The persistent negative net assets and losses present a critical risk of insolvency, limiting the company’s ability to invest, attract talent, or secure credit.
• Market Competition: Operating in a specialized health sector, the company may face strong competition from larger, better-capitalized firms with established client bases and regulatory know-how.
• Limited Scale: As a micro entity with minimal staffing and no fixed assets, scaling operational capability to meet growing demand or regulatory requirements may be challenging.
• Regulatory Compliance: The human health activities sector is typically highly regulated. Any failure to comply could result in fines, sanctions, or reputational damage.
• Lack of Clear PSC: Absence of declared persons with significant control could complicate governance and investor confidence.